Citations

Clear

6274 citation(s) found for "To, Andrew".

125: ASSOCIATION OF HYPOTHYROIDISM WITH COVID-19 OUTCOMES: RESULTS FROM THE SCCM DISCOVERY REGISTRY
Bogojevic, Marija , Sharma, Mayank , Nou, Abigail La, Hanson, Andrew C. , Schulte, Phillip J. , Qamar, Shahraz , Kumar, Vishakha K. , Gajić, Ognjen, Bhagra, Sumit , Pattan, Vishwanath , Garces, Juan Pablo Domecq , Bansal, Vikas , Singh, Romil , Tekin, Aysun , LeMahieu, Allison , Deo, Neha , Zec, Simon , Walkey, Allan J. , Gajic, Ognjen , Kashyap, Rahul

Mayo Clinic

Critical Care Medicine | December 16, 2021 | Volume: 50 | Issue: 1 | Pages: 45-45

10.1097/01.ccm.0000806824.45214.5b Get It

23: LENZILUMAB IN HOSPITALIZED BLACK/AFRICAN-AMERICAN COVID-19 PATIENTS: LIVE-AIR PHASE 3 STUDY RESULTS
Temesgen, Zelalem , Durrant, Cameron, Chappell, Dale, Ahmed, Omar, Kilcoyne, Adrian , Chappell, Gabrielle, Jordan, E. O., Burger, Charles D. , Libertin, Claudia R. , Ahmed, Omar, Jordan, Edward, Badley, Andrew D.

Mayo Clinic

Critical Care Medicine | December 16, 2021 | Volume: 50 | Issue: 1 | Pages: 12-12

10.1097/01.ccm.0000806560.97032.3f Get It

COVLIAS 1.0 vs. MedSeg: Artificial Intelligence-Based Comparative Study for Automated COVID-19 Computed Tomography Lung Segmentation in Italian and Croatian Cohorts
Suri, Jasjit S. , Agarwal, Sushant , Carriero, Alessandro , Paschè, Alessio , Danna, Pietro , Columbu, Marta, Saba, Luca , Višković, Klaudija , Mehmedović, Armin , Agarwal, Samriddhi, Gupta, Lakshya, Faa, Gavino , Singh, Inder M. , Turk, Monika, Chadha, Paramjit S., Johri, Amer M. , Khanna, Narendra N. , Laird, John R. , Pareek, Gyan , Miner, Martin , Sobel, David , Balestrieri, Antonella , Sfikakis, Petros P. , Tsoulfas, George, Protogerou, Athanase D. , Misra, Durga Prasanna , Agarwal, Vikas , Teji, Jagjit S. , Al-Maini, Mustafa , Dhanjil, Surinder, Rathore, Vijay , Fatemi, Mostafa , Krishnan, Pudukode R., Nagy, F. , Ruzsa, Zoltán , Naidu, Subbaram , Paraskevas, Kosmas I. , Danna, Pietro S C , Tsoulfas, George , Protogerou, Athanasios , Fatemi, Mostafa , Alizad, Azra , Ferenc, Nagy , Ruzsa, Zoltan , Paraskevas, Kosmas I , Misra, Durga Prasanna , Agarwal, Vikas , Faa, Gavino , Mehmedović, Armin , Agarwal, Sushant , Suri, Jasjit S. , Saba, Luca , Mavrogeni, Sophie , Kitas, George D. , Nicolaides, Andrew , Sharma, Aditya , Alizad, Azra , Gupta, Archna , Kalra, Mannudeep K.

Mayo Clinic

Diagnostics | December 15, 2021 | Volume: 11 | Issue: 12 | Pages: 2367

10.3390/diagnostics11122367 | PMID 34943603 Get It

(1) Background: COVID-19 computed tomography (CT) lung segmentation is critical for COVID lung severity diagnosis. Earlier proposed approaches during 2020–2021 were semiautomated or automated but not accurate, user-friendly, and industry-standard benchmarked. The proposed study compared the COVID Lung Image Analysis System, COVLIAS 1.0 (GBTI, Inc., and AtheroPointTM, Roseville, CA, USA, referred to as COVLIAS), against MedSeg, a web-based Artificial Intelligence (AI) segmentation tool, where COVLIAS uses hybrid deep learning (HDL) models for CT lung segmentation. (2) Materials and Methods: The proposed study used 5000 ITALIAN COVID-19 positive CT lung images collected from 72 patients (experimental data) that confirmed the reverse transcription-polymerase chain reaction (RT-PCR) test. Two hybrid AI models from the COVLIAS system, namely, VGG-SegNet (HDL 1) and ResNet-SegNet (HDL 2), were used to segment the CT lungs. As part of the results, we compared both COVLIAS and MedSeg against two manual delineations (MD 1 and MD 2) using (i) Bland–Altman plots, (ii) Correlation coefficient (CC) plots, (iii) Receiver operating characteristic curve, and (iv) Figure of Merit and (v) visual overlays. A cohort of 500 CROATIA COVID-19 positive CT lung images (validation data) was used. A previously trained COVLIAS model was directly applied to the validation data (as part of Unseen-AI) to segment the CT lungs and compare them against MedSeg. (3) Result: For the experimental data, the four CCs between COVLIAS (HDL 1) vs. MD 1, COVLIAS (HDL 1) vs. MD 2, COVLIAS (HDL 2) vs. MD 1, and COVLIAS (HDL 2) vs. MD 2 were 0.96, 0.96, 0.96, and 0.96, respectively. The mean value of the COVLIAS system for the above four readings was 0.96. CC between MedSeg vs. MD 1 and MedSeg vs. MD 2 was 0.98 and 0.98, respectively. Both had a mean value of 0.98. On the validation data, the CC between COVLIAS (HDL 1) vs. MedSeg and COVLIAS (HDL 2) vs. MedSeg was 0.98 and 0.99, respectively. For the experimental data, the difference between the mean values for COVLIAS and MedSeg showed a difference of <2.5%, meeting the standard of equivalence. The average running times for COVLIAS and MedSeg on a single lung CT slice were ~4 s and ~10 s, respectively. (4) Conclusions: The performances of COVLIAS and MedSeg were similar. However, COVLIAS showed improved computing time over MedSeg.
Inflammatory pseudotumor mimicking chronic pulmonary embolism or pulmonary artery sarcoma: Report of five cases
Liao, Xiaoyan , Bojanowski, Christine M. , Yen, Andrew , Kerr, Kim M. , Dumouchel, Justin, Auger, William R. , Madani, Michael M. , Wang, Huan‐You , Yi, Eunhee S. , Lin, Grace , Liao, Xiaoyan , Yen, Andrew, Pretorius, Victor

Mayo Clinic

Pulmonary Circulation | December 15, 2021 | Volume: 12 | Issue: 1 | Pages: No page available

10.1002/pul2.12004 | PMID 35506111 Get It

AbstractInflammatory pseudotumor (IPT), also known as plasma cell granuloma, is a rare lesion of unknown etiology that occurs in many organs, especially in the lung. Here we report five cases of IPT arising in pulmonary artery mimicking chronic thromboembolic disease, not previously documented in the literature. Those cases were identified at our institute among over 2500 pulmonary endarterectomy (PEA) specimens acquired from 2000 to 2017. The cohort included three men and two women with a median age of 41 years (range: 23–54). All patients presented with dyspnea and radiologic findings of pulmonary artery thromboembolism, some concerning for intimal sarcoma. The duration between disease onset and PEA ranged from 6 months to approximately 3 years. Histologically, all cases showed proliferation of spindle cells with marked inflammatory infiltrates composed predominantly of plasma cells, histiocytes, and small lymphocytes. Ancillary studies were performed in each case and ruled out other possibilities, such as sarcoma, lymphoma, plasmacytoma, IgG4‐related disease, and infection. IPT arising in pulmonary artery presenting clinically as acute or chronic thromboembolic disease is very unusual, in which clinical data, radiographic findings, and histopathologic features have to be integrated for reaching the proper diagnosis.
Building a precise machine-specific time structure of the spot and energy delivery model for a cyclotron-based proton therapy system
Zhao, Lewei , Zheng, Weili , Shen, Jiajian , Lee, Andrew , Yan, Di , Deraniyagala, Rohan, Stevens, Craig , Tang, Shikui, Ding, Xuanfeng , Shen, Jiajian , Liu, Gang , Li, Xiaoqiang

Mayo Clinic

Physics in Medicine & Biology | December 14, 2021 | Volume: 67 | Issue: 1 | Pages: 01NT01

10.1088/1361-6560/ac431c | PMID 34905732 Get It

Abstract Objective . We proposed an experimental approach to build a precise machine-specific beam delivery time (BDT) prediction and delivery sequence model for standard, volumetric, and layer repainting delivery based on a cyclotron accelerator system. Approach . Test fields and clinical treatment plans’ log files were used to experimentally derive three main beam delivery parameters that impacted BDT: energy layer switching time (ELST), spot switching time, and spot drill time. This derived machine-specific model includes standard, volumetric, and layer repainting delivery sequences. A total of 103 clinical treatment fields were used to validate the model. Main results . The study found that ELST is not stochastic in this specific machine. Instead, it is actually the data transmission time or energy selection time, whichever takes longer. The validation showed that the accuracy of each component of the BDT matches well between machine log files and the model’s prediction. The average total BDT was about (−0.74 ± 3.33)% difference compared to the actual treatment log files, which is improved from the current commercial proton therapy system’s prediction (67.22%±26.19%). Significance . An accurate BDT prediction and delivery sequence model was established for an cyclotron-based proton therapy system IBA ProteusPLUS ® . Most institutions could adopt this method to build a machine-specific model for their own proton system.
Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib
Bourne, Michael H. , Kottom, Theodore J. , Hebrink, Deanne, Choudhury, Malay , Leof, Edward B. , Hebrink, Deanne M, Kottom, Theodore J , Limper, Andrew H.

Mayo Clinic

Cells | December 13, 2021 | Volume: 10 | Issue: 12 | Pages: 3502

10.3390/cells10123502 | PMID 34944010 Get It

Idiopathic pulmonary fibrosis (IPF) remains an intractably fatal disorder, despite the recent advent of anti-fibrotic medication. Successful treatment of IPF, like many chronic diseases, may benefit from the concurrent use of multiple agents that exhibit synergistic benefit. In this light, phosphodiesterase type 5 inhibitors (PDE5-Is), have been studied in IPF primarily for their established pulmonary vascular effects. However, recent data suggest certain PDE5-Is, particularly vardenafil, may also reduce transforming growth factor beta 1 (TGF-β1) activation and extracellular matrix (ECM) accumulation, making them a potential target for therapy for IPF. We evaluated fibroblast TGF-β1-driven extracellular matrix (ECM) generation and signaling as well as epithelial mesenchymal transformation (EMT) with pretreatment using the PDE5-I vardenafil. In addition, combinations of vardenafil and nintedanib were evaluated for synergistic suppression of EMC using a fibronectin enzyme-linked immunosorbent assay (ELISA). Finally, the effects of vardenafil on fibrosis were investigated in a bleomycin mouse model. Our findings demonstrate that vardenafil suppresses ECM generation alone and also exhibits significant synergistic suppression of ECM in combination with nintedanib in vitro. Interestingly, vardenafil was shown to improve fibrosis markers and increase survival in bleomycin-treated mice. Vardenafil may represent a potential treatment for IPF alone or in combination with nintedanib. However, additional studies will be required.
National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories
Miller, W. Greg , Kaufman, Harvey W. , Levey, Andrew S. , Straseski, Joely A., Wilhelms, Kelly W. , Yu, Hoi Ying, Klutts, J. Stacey , Horowitz, Gary L., Lieske, John C. , Ennis, Jennifer, Bowling, James L., Lewis, M. J. T., Inker, Lesley A. , Lieske, John C , Hilborne, Lee H. , Lewis, Mary Jane, Montgomery, Elizabeth, Vassalotti, Joseph A.

Mayo Clinic

Clinical Chemistry | December 11, 2021 | Volume: 68 | Issue: 4 | Pages: 511-520

10.1093/clinchem/hvab278 | PMID 34918062 Get It

Abstract Recognizing that race is a social and not a biological construct, healthcare professionals and the public have called for removal of race in clinical algorithms. In response, the National Kidney Foundation and the American Society of Nephrology created the Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases to examine the issue and provide recommendations. The final report from the Task Force recommends calculating estimated glomerular filtration rate (eGFR) without a race coefficient using the recently published CKD-EPI 2021 creatinine (cr) and creatinine-cystatin C (cr-cys) equations. The Task Force recommends immediately replacing older eGFRcr equations (MDRD Study and CKD-EPI 2009) with the new CKD-EPI 2021 equation. In a 2019 survey by the College of American Pathologists, 23% of 6200 laboratories reporting eGFRcr used an incorrect equation that is not suitable for use with standardized creatinine measurements, 34% used the CKD-EPI 2009 equation and 43% used the MDRD Study 2006 equation re-expressed for standardized creatinine measurement. Rapid transition to using the CKD-EPI 2021 equation is an opportunity for laboratories to standardize to a single equation to eliminate differences in eGFRcr due to different equations used by different laboratories, and to report eGFR without use of race. We provide guidance to laboratories for implementing the CKD-EPI 2021 equations for both eGFRcr and eGFRcr-cys.
Additional C-type lectin receptors mediate interactions with Pneumocystis organisms and major surface glycoprotein
Kottom, Theodore J. , Carmona, Eva M. , Schaefbauer, Kyle, Limper, Andrew H. , Carmona, Eva M , Limper, Andrew H , Kottom, Theodore J

Mayo Clinic

Journal of Medical Microbiology | December 10, 2021 | Volume: 70 | Issue: 12 | Pages: No page available

10.1099/jmm.0.001470 | PMID 34889727 Get It

Introduction. Pathogen-associated molecular patterns’ (PAMPs) are microbial signatures that are recognized by host myeloid C-type lectin receptors (CLRs). These CLRs interact with micro-organisms via their carbohydrate recognition domains (CRDs) and engage signalling pathways within the cell resulting in pro-inflammatory and microbicidal responses. Gap statement. In this article, we extend our laboratory study of additional CLRs that recognize fungal ligands against Pneumocystis murina and Pneumocystis carinii and their purified major surface glycoproteins (Msgs). Aim. To study the potential of newly synthesized hFc-CLR fusions on binding to Pneumocystis and its Msg. Methods. A library of new synthesized hFc-CLR fusions was screened against Pneumocystis murina and Pneumocystis carinii organisms and their purified major surface glycoproteins (Msgs) found on the respective fungi via modified ELISA. Immunofluorescence assay (IFA) was implemented and quantified to verify results. mRNA expression analysis by quantitative PCR (q-PCR) was employed to detect respective CLRs found to bind fungal organisms in the ELISA and determine their expression levels in the mouse immunosuppressed Pneumocystis pneumonia (PCP) model. Results. We detected a number of the CLR hFc-fusions displayed significant binding with P. murina and P. carinii organisms, and similarly to their respective Msgs. Significant organism and Msg binding was observed for CLR members C-type lectin domain family 12 member A (CLEC12A), Langerin, macrophage galactose-type lectin-1 (MGL-1), and specific intracellular adhesion molecule-3 grabbing non-integrin homologue-related 3 (SIGNR3). Immunofluorescence assay (IFA) with the respective CLR hFc-fusions against whole P. murina life forms corroborated these findings. Lastly, we surveyed the mRNA expression profiles of the respective CLRs tested above in the mouse immunosuppressed Pneumocystis pneumonia (PCP) model and determined that macrophage galactose type C-type lectin (Mgl-1), implicated in recognizing terminal N-acetylgalactosamine (GalNAc) found in the glycoproteins of microbial pathogens was significantly up-regulated during infection. Conclusion. The data herein add to the growing list of CLRs recognizing Pneumocystis and provide insights for further study of organism/host immune cell interactions.
Genetic variants associated with circulating C‐reactive protein levels and colorectal cancer survival: Sex‐specific and lifestyle factors specific associations
Huang, Yu‐Han , Hua, Xinwei , Labadie, Julia , Harrison, Tabitha A. , Dai, James Y. , Lindström, Sara , Berndt, Sonja I. , Buchanan, Daniel D. , Casey, Graham , Gallinger, Steven , Gunter, Marc J. , Hoffmeister, Michael , Diergaarde, Brenda , Slattery, Martha L. , Brenner, Hermann , Chang‐Claude, Jenny , Joshi, Amit D. , Pai, Rish K. , Peters, Ulrike , Buchanan, Daniel D , Hoffmeister, Michael , Slattery, Martha L , Newcomb, Polly A. , Gunter, Marc J , Harrison, Tabitha A , Brenner, Hermann , Dai, James Y , Diergaarde, Brenda , Lin, Yi , Campbell, Peter T. , Jenkins, Mark A. , Sakoda, Lori C. , Schoen, Robert E. , White, Emily E. , Giles, Graham G. , Ma, Wenjie , Chan, Andrew T.

Mayo Clinic

International Journal of Cancer | December 10, 2021 | Volume: 150 | Issue: 9 | Pages: 1447-1454

10.1002/ijc.33897 | PMID 34888857 Get It

AbstractElevated blood levels of C‐reactive protein (CRP) have been linked to colorectal cancer (CRC) survival. We evaluated genetic variants associated with CRP levels and their interactions with sex and lifestyle factors in association with CRC‐specific mortality. Our study included 16 142 CRC cases from the International Survival Analysis in Colorectal Cancer Consortium. We identified 618 common single nucleotide polymorphisms (SNPs) associated with CRP levels from the NHGRI‐EBI GWAS Catalog. Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between SNPs and CRC‐specific mortality adjusting for age, sex, genotyping platform/study and principal components. We investigated their interactions with sex and lifestyle factors using likelihood ratio tests. Of 5472 (33.9%) deaths accrued over up to 10 years of follow‐up, 3547 (64.8%) were due to CRC. No variants were associated with CRC‐specific mortality after multiple comparison correction. We observed strong evidence of interaction between variant rs1933736 at FRK gene and sex in relation to CRC‐specific mortality (corrected Pinteraction = .0004); women had higher CRC‐specific mortality associated with the minor allele (HR = 1.11, 95% CI = 1.04‐1.19) whereas an inverse association was observed for men (HR = 0.88, 95% CI = 0.82‐0.94). There was no evidence of interactions between CRP‐associated SNPs and alcohol, obesity or smoking. Our study observed a significant interaction between sex and a CRP‐associated variant in relation to CRC‐specific mortality. Future replication of this association and functional annotation of the variant are needed.
Optimizing Web-Based Viewer of 4D CT Scans for Clinical Assessment of Injured Wrists
Holmes, David R., Thoreson, Andrew R., Breighner, Ryan E., Kakar, Sanjeev, Moran, Steven L., Leng, Shuai, Zhao, Kristin D., Zhao, Kristin D. , Trentadue, Taylor P , Holmes, David R., Thoreson, Andrew R., Breighner, Ryan E., Kakar, Sanjeev, Moran, Steven L., Leng, Shuai, Zhao, Kristin D.

Mayo Clinic

2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) | December 9, 2021 | Volume: No volume available | Issue: No issue available | Pages: 2405-2408

10.1109/embc46164.2021.9629999 | PMID 34891766 Get It